Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells

2014 ◽  
Vol 51 (1) ◽  
pp. 59-71 ◽  
Author(s):  
Pranapda Aumsuwan ◽  
Shabana I. Khan ◽  
Ikhlas A. Khan ◽  
Bharathi Avula ◽  
Larry A. Walker ◽  
...  
Planta Medica ◽  
2013 ◽  
Vol 79 (05) ◽  
Author(s):  
P Aumsuwan ◽  
SI Khan ◽  
IA Khan ◽  
LA Walker ◽  
AK Dasmahapatra

2009 ◽  
Vol 37 (01) ◽  
pp. 159-167 ◽  
Author(s):  
Mi-Kyung Park ◽  
Hyeok-Yi Kwon ◽  
Woong-Shick Ahn ◽  
Sumi Bae ◽  
Mee-Ra Rhyu ◽  
...  

We studied the estrogenic activity and cellular effect of wild yam extract in MCF-7 human breast cancer cells. The extract increased the activity of the progesterone receptor and pS2 genes at the mRNA levels in human breast cancer MCF-7 cells, although the effects were not as prominent as those of 17β-estradiol (E2). Western blot analysis showed that the level of estrogen receptor α protein was down-regulated after treatment with E2 or wild yam extract. Wild yam extract also inhibited proliferation of MCF-7 cells. These data indicate that wild yam extract acts as a weak phytoestrogen and protects against proliferation in human breast carcinoma MCF-7 cells.


2017 ◽  
Vol 1 (2) ◽  
pp. 67-75
Author(s):  
Roihatul Mutiah

Development of phytopharmaca for cancer until now has become a major step in overcoming the failure of cancer therapy. Calotrophis gigantea is one of the scientifically proven plants both in vitro and in vivo as a chemopreventive agent. This study aims to explain the efficacy and safety of Calotropis gigantea leaf extract (EDCG) and Calotropis gigantea root extract (EACG) on NIH3T3 cell, colon cancer cell WiDr and T47D breast cancer cells. From the analysis of MTT and Selectivity Index (SI) analysis showed that ethanol extract of leaf Calotropis gigantea (EDCG) can inhibit selective growth of selective colon cancer cells (SI 3) but not selective in inhibiting the growth of breast cancer cells T47D (SI 3 ). Calotropic gigantea (EACG) root ethanol extract is not selective in inhibiting the growth of colon cancer cells WiDr and breast cancer cells T47D (SI 3). Therefore EDCG can be recommended as a Phytopharmaca candidate with further proof through clinical trials.


2016 ◽  
Vol 187 ◽  
pp. 195-204 ◽  
Author(s):  
Jhi Biau Foo ◽  
Latifah Saiful Yazan ◽  
Yin Sim Tor ◽  
Agustono Wibowo ◽  
Norsharina Ismail ◽  
...  

2010 ◽  
Vol 34 (8) ◽  
pp. S49-S49
Author(s):  
Lei Wang ◽  
Xun Zhou ◽  
Lihong Zhou ◽  
Yong Chen ◽  
Xun Zhu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document